Perinatal HIV and Its Prevention: Progress Toward an HIV-free Generation

This publication has 55 references indexed in Scilit:

• Maternal or Infant Antiretroviral Drugs to Reduce HIV-1 Transmission
  New England Journal of Medicine, 2010
• Antiretroviral Regimens in Pregnancy and Breast-Feeding in Botswana
  New England Journal of Medicine, 2010
• Extended-dose nevirapine to 6 weeks of age for infants to prevent HIV transmission via breastfeeding in Ethiopia, India, and Uganda: an analysis of three randomised controlled trials
  The Lancet, 2008
• Intrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of mother-to-child transmission of HIV-1 in Kampala, Uganda: 18-month follow-up of the HIVNET 012 randomised trial
  The Lancet, 2003
• Two-Dose Intrapartum/Newborn Nevirapine and Standard Antiretroviral Therapy to Reduce Perinatal HIV TransmissionA Randomized Trial
  JAMA, 2002
• Efficacy of three short-course regimens of zidovudine and lamivudine in preventing early and late transmission of HIV-1 from mother to child in Tanzania, South Africa, and Uganda (Petra study): a randomised, double-blind, placebo-controlled trial
  The Lancet, 2002
• Combination Antiretroviral Strategies for the Treatment of Pregnant HIV-1–Infected Women and Prevention of Perinatal HIV-1 Transmission
  JAIDS Journal of Acquired Immune Deficiency Syndromes, 2002
• Prevention of Mother-to-Child HIV Transmission in Resource-Poor Countries
  JAMA, 2000
• Short-course oral zidovudine for prevention of mother-to-child transmission of HIV-1 in Abidjan, Côte d'Ivoire: a randomised trial
  The Lancet, 1999
• Reduction of Maternal-Infant Transmission of Human Immunodeficiency Virus Type 1 with Zidovudine Treatment
  New England Journal of Medicine, 1994